PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE PRESCRIBE
M M M M M
RS 6TH EDITION WOO ROBINSON TEST BANK
M M M M M M
, PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE CAREGIVER PRESCRIBERS 6T
M M M M M M
H EDITION WOO ROBINSON TEST BANK
M M M M M
CHMM1.MTheMRoleMofMtheMCaregiverMPractitionerM
MultipleMselection
IdentifyMtheMoptionMthatMbestMcompletesMtheMstatementMorManswersMtheMquestion.
M 1.MNurseMpractitionerMprescriptiveMauthorityMisMregulatedMby:
1. TheMNationalMCouncilMofMStateMBoardsMofMNursing
2. TheMU.S.MMedicalMdrugMEnforcementMAdministration
3. TheMStateMBoardMofMNursingMforMeachMstate
4. TheMStateMBoardMofMPharmacy
M
2.MTheMbenefitsMtoMtheMhospitalMclientMofMhavingManMAdvancedMPracticeMRegisteredMCaregiverM(
APRN)MprescriberMinclude:
1. CaregiversMknowMmoreMaboutMPharmacologyMthanMotherMprescribersMbecauseMtheyMt
akeMitMbothMinMtheirMbasicMnursingMprogramMandMinMtheirMAPRNMprogram.
2. CaregiversMcareMforMtheMhospitalMclientMfromMaMholisticMapproachMandMincludeMt
heMhospitalMclientMinMdecisionMmakingMregardingMtheirMcare.
3. APRNsMareMlessMlikelyMtoMprescribeMnarcoticsMandMotherMcontrolledMsubstances.
4. APRNsMareMableMtoMprescribeMindependentlyMinMallMstates,MwhereasMaMphysician’
sMassistantMneedsMtoMhaveMaMphysicianMsupervisingMtheirMpractice.
M 3.MClinicalMjudgmentMinMprescribingMincludes:
1. FactoringMinMtheMcostMtoMtheMhospitalMclientMofMtheMmedicationMprescribed
2. AlwaysMprescribingMtheMnewestMmedicationMavailableMforMtheMdiseaseMprocess
3. HandingMoutMmedicalMdrugMsamplesMtoMpoorMhospitalMclients
4. PrescribingMallMgenericMmedicationsMtoMcutMcosts
M 4.MCriteriaMforMchoosingManMeffectiveMmedicalMdrugMforMaMdisorderMinclude:
1. AskingMtheMhospitalMclientMwhatMmedicalMdrugMtheyMthinkMwouldMworkMbestMforMthem
2. ConsultingMnationallyMrecognizedMguidelinesMforMdiseaseMmanagement
3. PrescribingMmedicationsMthatMareMavailableMasMsamplesMbeforeMwritingMaMprescription
4. FollowingMU.S.MDrugMEnforcementMAdministrationMguidelinesMforMprescribing
M 5.MCaregiverMpractitionerMpracticeMmayMthriveMunderMhealth-careMreformMbecauseMof:
1. TheMdemonstratedMabilityMofMcaregiverMpractitionersMtoMcontrolMcostsMandMimproveMho
spitalMclientMoutcomes
2. TheMfactMthatMcaregiverMpractitionersMwillMbeMableMtoMpracticeMindependently
3. TheMfactMthatMcaregiverMpractitionersMwillMhaveMfullMreimbursementMunderMhealth-
careMreform
4. TheMabilityMtoMshiftMaccountabilityMforMMedicaidMtoMtheMstateMlevel
,CHMM1.MTheMRoleMofMtheMCaregiverMPractitionerMA
nswerMSection
MULTIPLEMSELECTION
1.MACCU 3 PTS: 1
RATEMAN
SWER:
2.MACCU 2 PTS: 1
RATEMAN
SWER:
3.MACCU 1 PTS: 1
RATEMAN
SWER:
4.MACCU 2 PTS: 1
RATEMAN
SWER:
5.MACCU 1 PTS: 1
RATEMAN
SWER:
CHMM2.MReviewMofMBasicMPrinciplesMofMPharmacology
MultipleMselection
IdentifyMtheMoptionMthatMbestMcompletesMtheMstatementMorManswersMtheMquestion.
M
1.MAMhospitalMclient’sMnutritionalMintakeMandMlaboratoryMresultsMreflectMhypoalbuminemia.MThisMi
sMcriticalMtoMprescribingMbecause:
1. DistributionMofMmedicalMdrugsMtoMtargetMtissueMmayMbeMaffected.
2. TheMsolubilityMofMtheMmedicalMdrugMwillMnotMmatchMtheMsiteMofMabsorption.
3. ThereMwillMbeMlessMfreeMmedicalMdrugMavailableMtoMgenerateManMeffect.
4. MedicalMdrugsMboundMtoMalbuminMareMreadilyMexcretedMbyMtheMkidneys.
M 2.MMedicalMdrugsMthatMhaveMaMsignificantMfirst-passMeffect:
1. MustMbeMgivenMbyMtheMenteralM(oral)MrouteMonly
2. BypassMtheMhepaticMcirculation
3. AreMrapidlyMmetabolizedMbyMtheMliverMandMmayMhaveMlittleMifManyMdesiredMaction
4. AreMconvertedMbyMtheMliverMtoMmoreMactiveMandMfat-solubleMforms
M 3.MTheMrouteMofMexcretionMofMaMvolatileMmedicalMdrugMwillMlikelyMbeMthe:
1. Kidneys
2. Lungs
3. BileMandMfeces
4. Skin
M
4.MMedroxyprogesteroneM(DepoMProvera)MisMprescribedMintramuscularlyM(IM)MtoMcreateMaMst
orageMreservoirMofMtheMmedicalMdrug.MStorageMreservoirs:
1. AssureMthatMtheMmedicalMdrugMwillMreachMitsMintendedMtargetMtissue
2. AreMtheMreasonMforMgivingMloadingMdoses
3. IncreaseMtheMlengthMofMtimeMaMmedicalMdrugMisMavailableMandMactive
4. AreMmostMcommonMinMcollagenMtissues
, M 5.MTheMNPMchoosesMtoMgiveMcephalexinMeveryM8MhoursMbasedMonMknowledgeMofMtheMmedicalMdrug’s:
1. PropensityMtoMgoMtoMtheMtargetMreceptor
2. BiologicalMhalf-life
3. Pharmacodynamics
4. SafetyMandMsideMeffects
6.MAzithromycinMdosingMrequiresMthatMtheMfirstMday’sMdosageMbeMtwiceMthoseMofMtheMotherM4Mdays
MofMtheMprescription.MThisMisMconsideredMaMloadingMdose.MAMloadingMdose:
1. RapidlyMachievesMmedicalMdrugMlevelsMinMtheMtherapeuticMrange
2. RequiresMfour-MtoMfive-half-livesMtoMattain
3. IsMinfluencedMbyMrenalMfunction
4. IsMdirectlyMrelatedMtoMtheMmedicalMdrugMcirculatingMtoMtheMtargetMtissues
M
7.MTheMpointMinMtimeMonMtheMmedicalMdrugMconcentrationMcurveMthatMindicatesMtheMfirstMsignMofMaMther
apeuticMeffectMisMthe:
1. MinimumMadverseMeffectMlevel
2. PeakMofMaction
3. OnsetMofMaction
4. TherapeuticMrange
M 8.MPhenytoinMrequiresMthatMaMtroughMlevelMbeMdrawn.MPeakMandMtroughMlevelsMareMdone:
1. WhenMtheMmedicalMdrugMhasMaMwideMtherapeuticMrange
2. WhenMtheMmedicalMdrugMwillMbeMadministeredMforMaMshortMtimeMonly
3. WhenMthereMisMaMhighMcorrelationMbetweenMtheMdoseMandMsaturationMofMreceptorMsites
4. ToMdetermineMifMaMmedicalMdrugMisMinMtheMtherapeuticMrange
M
9.MAMlaboratoryMresultMindicatesMthatMtheMpeakMlevelMforMaMmedicalMdrugMisMaboveMtheMminimumMtoxicMconcentrat
ion.
ThisMmeansMthatMthe:
1. ConcentrationMwillMproduceMtherapeuticMeffects
2. ConcentrationMwillMproduceManMadverseMresponse
3. TimeMbetweenMdosesMmustMbeMshortened
4. DurationMofMactionMofMtheMmedicalMdrugMisMtooMlong
M MM 10.MMedicalMdrugsMthatMareMreceptorMagonistsMmayMdemonstrateMwhatMproperty?
1. IrreversibleMbindingMtoMtheMmedicalMdrugMreceptorMsite
2. UpregulationMwithMchronicMuse
3. DesensitizationMorMdownregulationMwithMcontinuousMuse
4. InverseMrelationshipMbetweenMmedicalMdrugMconcentrationMandMmedicalMdrugMaction
M MM 11.MMedicalMdrugsMthatMareMreceptorMantagonists,MsuchMasMbetaMblockers,MmayMcause:
1. DownregulationMofMtheMmedicalMdrugMreceptor
2. AnMexaggeratedMresponseMifMabruptlyMdiscontinued
3. PartialMblockadeMofMtheMeffectsMofMagonistMmedicalMdrugs
4. AnMexaggeratedMresponseMtoMcompetitiveMmedicalMdrugMagonists
M MM 12.MFactorsMthatMaffectMgastricMmedicalMdrugMabsorptionMinclude:
1. LiverMenzymeMactivity
2. Protein-bindingMpropertiesMofMtheMmedicalMdrugMmolecule
3. LipidMsolubilityMofMtheMmedicalMdrug
4. AbilityMtoMchewMandMswallow
M M M M M
RS 6TH EDITION WOO ROBINSON TEST BANK
M M M M M M
, PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE CAREGIVER PRESCRIBERS 6T
M M M M M M
H EDITION WOO ROBINSON TEST BANK
M M M M M
CHMM1.MTheMRoleMofMtheMCaregiverMPractitionerM
MultipleMselection
IdentifyMtheMoptionMthatMbestMcompletesMtheMstatementMorManswersMtheMquestion.
M 1.MNurseMpractitionerMprescriptiveMauthorityMisMregulatedMby:
1. TheMNationalMCouncilMofMStateMBoardsMofMNursing
2. TheMU.S.MMedicalMdrugMEnforcementMAdministration
3. TheMStateMBoardMofMNursingMforMeachMstate
4. TheMStateMBoardMofMPharmacy
M
2.MTheMbenefitsMtoMtheMhospitalMclientMofMhavingManMAdvancedMPracticeMRegisteredMCaregiverM(
APRN)MprescriberMinclude:
1. CaregiversMknowMmoreMaboutMPharmacologyMthanMotherMprescribersMbecauseMtheyMt
akeMitMbothMinMtheirMbasicMnursingMprogramMandMinMtheirMAPRNMprogram.
2. CaregiversMcareMforMtheMhospitalMclientMfromMaMholisticMapproachMandMincludeMt
heMhospitalMclientMinMdecisionMmakingMregardingMtheirMcare.
3. APRNsMareMlessMlikelyMtoMprescribeMnarcoticsMandMotherMcontrolledMsubstances.
4. APRNsMareMableMtoMprescribeMindependentlyMinMallMstates,MwhereasMaMphysician’
sMassistantMneedsMtoMhaveMaMphysicianMsupervisingMtheirMpractice.
M 3.MClinicalMjudgmentMinMprescribingMincludes:
1. FactoringMinMtheMcostMtoMtheMhospitalMclientMofMtheMmedicationMprescribed
2. AlwaysMprescribingMtheMnewestMmedicationMavailableMforMtheMdiseaseMprocess
3. HandingMoutMmedicalMdrugMsamplesMtoMpoorMhospitalMclients
4. PrescribingMallMgenericMmedicationsMtoMcutMcosts
M 4.MCriteriaMforMchoosingManMeffectiveMmedicalMdrugMforMaMdisorderMinclude:
1. AskingMtheMhospitalMclientMwhatMmedicalMdrugMtheyMthinkMwouldMworkMbestMforMthem
2. ConsultingMnationallyMrecognizedMguidelinesMforMdiseaseMmanagement
3. PrescribingMmedicationsMthatMareMavailableMasMsamplesMbeforeMwritingMaMprescription
4. FollowingMU.S.MDrugMEnforcementMAdministrationMguidelinesMforMprescribing
M 5.MCaregiverMpractitionerMpracticeMmayMthriveMunderMhealth-careMreformMbecauseMof:
1. TheMdemonstratedMabilityMofMcaregiverMpractitionersMtoMcontrolMcostsMandMimproveMho
spitalMclientMoutcomes
2. TheMfactMthatMcaregiverMpractitionersMwillMbeMableMtoMpracticeMindependently
3. TheMfactMthatMcaregiverMpractitionersMwillMhaveMfullMreimbursementMunderMhealth-
careMreform
4. TheMabilityMtoMshiftMaccountabilityMforMMedicaidMtoMtheMstateMlevel
,CHMM1.MTheMRoleMofMtheMCaregiverMPractitionerMA
nswerMSection
MULTIPLEMSELECTION
1.MACCU 3 PTS: 1
RATEMAN
SWER:
2.MACCU 2 PTS: 1
RATEMAN
SWER:
3.MACCU 1 PTS: 1
RATEMAN
SWER:
4.MACCU 2 PTS: 1
RATEMAN
SWER:
5.MACCU 1 PTS: 1
RATEMAN
SWER:
CHMM2.MReviewMofMBasicMPrinciplesMofMPharmacology
MultipleMselection
IdentifyMtheMoptionMthatMbestMcompletesMtheMstatementMorManswersMtheMquestion.
M
1.MAMhospitalMclient’sMnutritionalMintakeMandMlaboratoryMresultsMreflectMhypoalbuminemia.MThisMi
sMcriticalMtoMprescribingMbecause:
1. DistributionMofMmedicalMdrugsMtoMtargetMtissueMmayMbeMaffected.
2. TheMsolubilityMofMtheMmedicalMdrugMwillMnotMmatchMtheMsiteMofMabsorption.
3. ThereMwillMbeMlessMfreeMmedicalMdrugMavailableMtoMgenerateManMeffect.
4. MedicalMdrugsMboundMtoMalbuminMareMreadilyMexcretedMbyMtheMkidneys.
M 2.MMedicalMdrugsMthatMhaveMaMsignificantMfirst-passMeffect:
1. MustMbeMgivenMbyMtheMenteralM(oral)MrouteMonly
2. BypassMtheMhepaticMcirculation
3. AreMrapidlyMmetabolizedMbyMtheMliverMandMmayMhaveMlittleMifManyMdesiredMaction
4. AreMconvertedMbyMtheMliverMtoMmoreMactiveMandMfat-solubleMforms
M 3.MTheMrouteMofMexcretionMofMaMvolatileMmedicalMdrugMwillMlikelyMbeMthe:
1. Kidneys
2. Lungs
3. BileMandMfeces
4. Skin
M
4.MMedroxyprogesteroneM(DepoMProvera)MisMprescribedMintramuscularlyM(IM)MtoMcreateMaMst
orageMreservoirMofMtheMmedicalMdrug.MStorageMreservoirs:
1. AssureMthatMtheMmedicalMdrugMwillMreachMitsMintendedMtargetMtissue
2. AreMtheMreasonMforMgivingMloadingMdoses
3. IncreaseMtheMlengthMofMtimeMaMmedicalMdrugMisMavailableMandMactive
4. AreMmostMcommonMinMcollagenMtissues
, M 5.MTheMNPMchoosesMtoMgiveMcephalexinMeveryM8MhoursMbasedMonMknowledgeMofMtheMmedicalMdrug’s:
1. PropensityMtoMgoMtoMtheMtargetMreceptor
2. BiologicalMhalf-life
3. Pharmacodynamics
4. SafetyMandMsideMeffects
6.MAzithromycinMdosingMrequiresMthatMtheMfirstMday’sMdosageMbeMtwiceMthoseMofMtheMotherM4Mdays
MofMtheMprescription.MThisMisMconsideredMaMloadingMdose.MAMloadingMdose:
1. RapidlyMachievesMmedicalMdrugMlevelsMinMtheMtherapeuticMrange
2. RequiresMfour-MtoMfive-half-livesMtoMattain
3. IsMinfluencedMbyMrenalMfunction
4. IsMdirectlyMrelatedMtoMtheMmedicalMdrugMcirculatingMtoMtheMtargetMtissues
M
7.MTheMpointMinMtimeMonMtheMmedicalMdrugMconcentrationMcurveMthatMindicatesMtheMfirstMsignMofMaMther
apeuticMeffectMisMthe:
1. MinimumMadverseMeffectMlevel
2. PeakMofMaction
3. OnsetMofMaction
4. TherapeuticMrange
M 8.MPhenytoinMrequiresMthatMaMtroughMlevelMbeMdrawn.MPeakMandMtroughMlevelsMareMdone:
1. WhenMtheMmedicalMdrugMhasMaMwideMtherapeuticMrange
2. WhenMtheMmedicalMdrugMwillMbeMadministeredMforMaMshortMtimeMonly
3. WhenMthereMisMaMhighMcorrelationMbetweenMtheMdoseMandMsaturationMofMreceptorMsites
4. ToMdetermineMifMaMmedicalMdrugMisMinMtheMtherapeuticMrange
M
9.MAMlaboratoryMresultMindicatesMthatMtheMpeakMlevelMforMaMmedicalMdrugMisMaboveMtheMminimumMtoxicMconcentrat
ion.
ThisMmeansMthatMthe:
1. ConcentrationMwillMproduceMtherapeuticMeffects
2. ConcentrationMwillMproduceManMadverseMresponse
3. TimeMbetweenMdosesMmustMbeMshortened
4. DurationMofMactionMofMtheMmedicalMdrugMisMtooMlong
M MM 10.MMedicalMdrugsMthatMareMreceptorMagonistsMmayMdemonstrateMwhatMproperty?
1. IrreversibleMbindingMtoMtheMmedicalMdrugMreceptorMsite
2. UpregulationMwithMchronicMuse
3. DesensitizationMorMdownregulationMwithMcontinuousMuse
4. InverseMrelationshipMbetweenMmedicalMdrugMconcentrationMandMmedicalMdrugMaction
M MM 11.MMedicalMdrugsMthatMareMreceptorMantagonists,MsuchMasMbetaMblockers,MmayMcause:
1. DownregulationMofMtheMmedicalMdrugMreceptor
2. AnMexaggeratedMresponseMifMabruptlyMdiscontinued
3. PartialMblockadeMofMtheMeffectsMofMagonistMmedicalMdrugs
4. AnMexaggeratedMresponseMtoMcompetitiveMmedicalMdrugMagonists
M MM 12.MFactorsMthatMaffectMgastricMmedicalMdrugMabsorptionMinclude:
1. LiverMenzymeMactivity
2. Protein-bindingMpropertiesMofMtheMmedicalMdrugMmolecule
3. LipidMsolubilityMofMtheMmedicalMdrug
4. AbilityMtoMchewMandMswallow
